Evaluating heterogeneity in ASD symptomatology, cognitive ability, and adaptive functioning among 16p11.2 CNV carriers.
Among 16p11.2 carriers, birth problems and extra gene hits worsen outcomes, while girls fare better.
01Research in Context
What this study did
The team looked at kids and adults who carry a 16p11.2 deletion or duplication. These chunks of missing or extra DNA raise autism risk.
They asked: do birth problems or other gene changes make autism traits, IQ, or daily-living scores worse?
What they found
Extra birth stress and second genetic "hits" worsened autism traits and lowered IQ in the deletion group. Duplication carriers were hurt only by second genetic hits.
Girls with the same DNA change kept higher skills than boys, showing a clear sex shield.
How this fits with other research
Choi et al. (2023) studied the same deletion carriers and adds vision trouble: their brains switch eye dominance more slowly, so add visual tests to your assessment list.
Demily et al. (2018) saw the same "CNV-plus-second-hit" pattern in 22q11.2 duplications, backing the idea that one genetic change rarely tells the whole story.
Perales-Marín et al. (2021) first linked birth problems to later autism in the general ASD pool; Heald et al. (2020) now show the effect is even stronger when 16p11.2 is already in play.
Why it matters
If a client has 16p11.2, ask parents about prenatal or birth complications and any extra genetic findings. Flag girls for quicker progress and boys for closer monitoring. Pair your behavior plan with vision screening and extra teaching loops for adaptive skills.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Add one quick parent question: 'Any prenatal or delivery issues?' and note the answer in the assessment file.
02At a glance
03Original abstract
Individuals with 16p11.2 copy number variant (CNV) show considerable phenotypic heterogeneity. Although autism spectrum disorder (ASD) is reported in approximately 20-23% of individuals with 16p11.2 CNVs, ASD-associated symptoms are observed in those without a clinical ASD diagnosis. Previous work has shown that genetic variation and prenatal and perinatal birth complications influence ASD risk and symptom severity. This study examined the impact of genetic and environmental risk factors on phenotypic heterogeneity among 16p11.2 CNV carriers. Participants included individuals with a 16p11.2 deletion (N = 96) or duplication (N = 77) with exome sequencing from the Simons VIP study. The presence of prenatal factors, perinatal events, additional genetic events, and gender was studied. Regression analyses examined the contribution of each risk factor on ASD symptomatology, cognitive functioning, and adaptive abilities. For deletion carriers, perinatal and additional genetic events were associated with increased ASD symptomatology and decrements in cognitive and adaptive functioning. For duplication carriers, secondary genetic events were associated with greater cognitive impairments. Being female sex was a protective factor for both deletion and duplication carriers. Our findings suggest that ASD-associated risk factors contribute to the variability in symptom presentation in individuals with 16p11.2 CNVs. LAY SUMMARY: There are a wide range of autism spectrum disorder (ASD) symptoms and abilities observed for individuals with genetic changes of the 16p11.2 region. Here, we found perinatal complications contributed to more severe ASD symptoms (deletion carriers) and additional genetic mutations contributed to decreased cognitive abilities (deletion and duplication carriers). A potential protective factor was also observed for females with 16p11.2 variations. Autism Res 2020, 13: 1300-1310. © 2020 International Society for Autism Research, Wiley Periodicals, Inc.
Autism research : official journal of the International Society for Autism Research, 2020 · doi:10.1002/aur.2332